Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014299 |
---|---|
Receipt number | R000016650 |
Scientific Title | Phase II study of erlotinib monotherapy for patients with advanced stage of non-small cell lung cancer, undetectable epidermal growth factor receptor (EGFR) mutations by PNA LNA PCR clamp method, but positive immuno-staining with anti-EGFR mutation-specific antibodies. |
Date of disclosure of the study information | 2014/07/01 |
Last modified on | 2016/08/05 13:23:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/06/18 12:23:01 | ||
2 | Update | 2014/06/18 16:41:40 | Recruitment status |
|
3 | Update | 2014/12/19 09:40:11 | Key exclusion criteria |
|
4 | Update | 2016/08/05 13:23:11 | Recruitment status |